MARK2 Regulates Chemotherapeutic Responses Through Class IIa HDAC-YAP Axis in Pancreatic Cancer

Through a Phos-tag-based kinome-wide screen, the authors identified microtubule affinity-regulating kinase proteins (MARK2) as a critical regulator for paclitaxel chemosensitivity in PDAC.